Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Skin & Cosmetic
GHK-Cu
Currently unavailable
Copper(II) glycyl-L-histidyl-L-lysine tripeptide
Strength
50 mg
Vial count
Unspecified
Strength of evidence
Early human studies
Research summary
Copper-binding tripeptide studied mainly in topical cosmetic formulations and in vitro skin models.
Regulatory status
Cosmetic topical use is regulated separately; injectable forms are not approved.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.